Anna Wenger
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 9
- Chromatin Remodeling and Cancer 2
- Circular RNAs in diseases 2
- Genetics 10
- Glioma Diagnosis and Treatment 10
- Genetics and Neurodevelopmental Disorders 2
- Co-authors
- Helena Carén (13 shared papers)Teresia Kling (9 shared papers)Thomas Olsson Bontell (4 shared papers)Asgeir Store Jakola (4 shared papers)Sandra Ferreyra Vega (4 shared papers)Stephan Beck (1 shared paper)Emelie Wesén (1 shared paper)Fredrik Westerlund (1 shared paper)
- Journals
- Clinical Epigenetics (2 papers)Oncotarget (2 papers)Cancers (1 paper)Clinical Cancer Research (1 paper)Acta Neuropathologica Communications (1 paper)
- Partner nations
- SwedenUnited KingdomNorway
In The Last Decade
Anna Wenger
15 papers receiving 381 citations
Peers
Comparison fields: 5 of 64
- Genetics 165
- Cancer Research 116
- Molecular Biology 242
- Developmental Neuroscience 10
- Neurology 34
Countries citing papers authored by Anna Wenger
This map shows the geographic impact of Anna Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wenger more than expected).
Fields of papers citing papers by Anna Wenger
This network shows the impact of papers produced by Anna Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wenger. The network helps show where Anna Wenger may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Wenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 83 | |
| 2 | 2017 | 61 | |
| 3 | 2017 | 50 | |
| 4 | 2017 | 41 | |
| 5 | 2017 | 28 | |
| 6 | 2020 | 27 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2018 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2019 | 8 | |
| 12 | 2016 | 8 | |
| 13 | 2017 | 8 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 4 |
About Anna Wenger
Anna Wenger is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Rheumatology, having authored 15 papers that have together received 382 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (10 papers), Epigenetics and DNA Methylation (9 papers), MicroRNA in disease regulation (3 papers), Chromatin Remodeling and Cancer (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Cancer Cells and Metastasis (2 papers), Circular RNAs in diseases (2 papers) and Neurogenesis and neuroplasticity mechanisms (2 papers). The work is most often cited by research in Genetics (165 citations), Cancer Research (116 citations), Molecular Biology (242 citations), Developmental Neuroscience (10 citations) and Neurology (34 citations). Anna Wenger has collaborated with scholars based in Sweden, United Kingdom and Norway. Frequent co-authors include Helena Carén, Teresia Kling, Thomas Olsson Bontell, Asgeir Store Jakola, Sandra Ferreyra Vega, Stephan Beck, Emelie Wesén, Fredrik Westerlund, Elin K. Esbjörner and Anna Danielsson. Their work appears in journals such as Clinical Epigenetics, Oncotarget, Cancers, Clinical Cancer Research and Acta Neuropathologica Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.